MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2017 International Congress

June 4-8, 2017. Vancouver, BC.

View by Title View Sessions
View by Date
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Multiple modality biomarker prediction of cognitive impairment in prospectively followed de novo Parkinson disease

    D. Weintraub (Philadelphia, PA, USA)

  • Multiple myeloma induced parkinsonism

    H. DS, V. Paramanandam, P.c. N (Chennai, India)

  • Multiple Neural Networks dysfunction in Primary Blepharospasm: An Independent Components Analysis Study

    X. Huang, Z.-h. Liang, M.-r. Zhu (Dalian, China)

  • Multivariate analysis of writer`s cramp: a study with advanced multi-channel microelectrode recording system

    V. Rama raju, R. Borgohain (Hyderabad, India)

  • Mutant DNAJC13 modulates accumulation and toxicity of alpha-synuclein through altered endosomal trafficking in cell and fly models of Parkinson’s disease

    T. Hasegawa, S. Yoshida, M. Suzuki, J. Kobayashi, N. Sugeno, K. Sekiguchi, M. Edura, A. Kikuchi, A. Takeda, Y. Nagai, M. Aoki (Sendai, Japan)

  • Mutational analysis of COQ2 in Chinese patients with multiple-system atrophy

    J. Zhang, Y. Hao, Y. Chen, M. Ding, X. Zhang, W. Gu (Beijing, China)

  • Myoclonus in adult onset Huntington’s disease

    S. McAllister, S. Shipley, J. Shah, R. Fekete (New York, NY, USA)

  • Myoclonus in the Elderly: Retrospective Analysis of Clinical and Electrophysiological characteristics of patients referred to an electrophysiology laboratory

    M. Kiziltan, A. Gunduz, M. Tutuncu, U. Uygunoglu, A. Sifoglu, S. Ertan, H. Apaydin, M. Bozluolcay, S. Saip, G. Kiziltan (Istanbul, Turkey)

  • Myths and Misconceptions Regarding Huntington’s Disease in Peru

    A. Vishnevetsky, M. Illanes-Manrique, M. Inca-Martinez, M. Cornejo-Olivas (Philadelphia, PA, USA)

  • ND0612 (levodopa/carbidopa for subcutaneous infusion) achieves stable levodopa plasma levels when administered in low and high doses in patients with PD

    N. Giladi, Y. Caraco, T. Gurevich, R. Djaldetti, L. Adar, T. Rachmilewitz Minei, S. Oren (Tel Aviv, Israel)

  • « Previous Page
  • 1
  • …
  • 92
  • 93
  • 94
  • 95
  • 96
  • …
  • 155
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley